Showing results (161-170 of 1,009) with videos related to

Sort By:
Pageof 101
Cancer Research Communications|November 3, 2023
Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case-Control StudyHenriette C Jodal, Eddymurphy U Akwiwu, Margriet Lemmens, et al.
Cancer Research Communications|July 21, 2023
A Th1-like CD4+ T-cell Cluster That Predicts Disease-free Survival in Early-stage Lung CancerAkitoshi Yanagihara, Satoshi Yamasaki, Kosuke Hashimoto, et al.
Cancer Research Communications|July 13, 2023
The African-centric P47S Variant of TP53 Confers Immune Dysregulation and Impaired Response to Immune Checkpoint InhibitionDavid C Stieg, Joshua L D Parris, Tyler Hong Loong Yang, et al.
Cancer Research Communications|July 10, 2023
Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine GlioblastomaMichal Nisnboym, Sarah R Vincze, Zujian Xiong, et al.
Cancer Research Communications|August 16, 2023
Cancer Epidemiology in the Northeastern United States (2013-2017)Judy R Rees, Julie E Weiss, Christine M Gunn, et al.
Cancer Research Communications|August 2, 2023
Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic VulnerabilitiesIan Ganly, Fengshen Kuo, Vladimir Makarov, et al.
Cancer Research Communications|August 14, 2023
Targeted Single-cell Isolation of Spontaneously Escaping Live Melanoma Cells for Comparative TranscriptomicsJacqueline L E Tearle, Satya N V Arjunan, Szun S Tay, et al.
Cancer Research Communications|August 14, 2023
Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck CancerMyrto Moutafi, Georgia-Angeliki Koliou, George Papaxoinis, et al.
Cancer Research Communications|August 24, 2023
Natural Killer Cell Activation by Ubiquitin-specific Protease 6 Mediates Tumor Suppression in Ewing SarcomaKanika Jain, Ian C Henrich, Laura Quick, et al.
Cancer Research Communications|September 4, 2023
Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK InhibitorShruti Lal, Neil E Bhola, Bee-Chun Sun, et al.
Pageof 101